Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada

References

• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370(9589):741–750.
   Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–2128.
   Google Scholar
• Benady S. The Human and Economic Burden of COPD: A Leading Cause of Hospital Admission in Canada. The Canadian Thoracic Society; 2010. Ottawa, Canada.
   Google Scholar
• Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999; 54(8):737–741.
   Google Scholar
• Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD 2012; 9(3):216–226.
   Google Scholar
• Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176(12):1179–1184.
   Google Scholar
• Nie JX, Wang L, Upshur RE. Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J 2007; 14(8):485–489.
   Google Scholar
• Gershon AS, Hwee J, Victor JC Wilton AS, To T. Trends in socioeconomic status–related differences in mortality among people with chronic obstructive pulmonary disease. Annals of the American Thoracic Society 2014, 11(8): 1195–1202.
   Google Scholar
• Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356(8):775–789.
   Google Scholar
• Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax 2006; 61(10):854–862.
   Google Scholar
• Blanc PD, Eisner MD, Yelin EH, et al. Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(3):483–490.
   Google Scholar
• Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119(6):1691–1695.
   Google Scholar
• Gershon A, Croxford R, To T, et al. Comparison of inhaled long-acting beta-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Ann Intern Med 2011; 154(9):583–592.
   Google Scholar
• PCCF+ Version 4D User's Guide (Geocodes/PCCF). Automated Geographic Coding Based on the Statistics Canada Postal Code Conversion Files, Including Postal Codes to December 2003 (computer program). Ottawa: Statistics Canada; 2004.
   Google Scholar
• Finkelstein MM. Ecologic proxies for household income: how well do they work for the analysis of health and health care utilization? Canadian J Publ Health 2004; 95(2):90–94.
   PubMed Web of Science ®Google Scholar
• Matheson FI, Dunn JR, Smith KL, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Publ Health 2012; 103(8 Suppl 2):S12–S16.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf
   Google Scholar
• Reid RJ, MacWilliam L, Verhulst L, Roos N, Atkinson M. Performance of the ACG case-mix system in two Canadian provinces. Med Care 2001; 39(1):86–99.
   Google Scholar
• The Johns Hopkins University ACG Case-Mix System (computer program). Version 8.0. Baltimore, MD: The John Hopkins University; 2006.
   Google Scholar
• McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157(10):940–943.
   Google Scholar
• O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 2007; 14 Suppl B:5B–32B.
   PubMed Web of Science ®Google Scholar
• Shah BR, Booth GL, Lipscombe LL, Feig DS, Bhattacharyya OK, Bierman AS. Near equality in quality for medication utilization among older adults with diabetes with universal medication insurance in Ontario, Canada. J Eval Clin Pract 2014; 20(2):176–183
   PubMed Web of Science ®Google Scholar
• Bierman AS, Pugh MJ, Dhalla I, et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother 2007; 5(2):147–161.
   Google Scholar
• Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr 2011; 11:79.
   Google Scholar
• Borkhoff CM, Saskin R, Rabeneck L, et al. Disparities in Receipt of Screening Tests for Cancer, Diabetes and High Cholesterol in Ontario, Canada: A Population-based Study Using Area-based Methods. Can J Publ Health 2013; 104(4):e284–e290.
   Google Scholar
• Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999; 341(18):1359–1367.
   Google Scholar
• Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002; 33(1):268–273.
   Google Scholar
• Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011; 365(22):2088–2097.
   Google Scholar
• Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Amer J Publ Health 1992; 82(5):703–710.
   Google Scholar
• Alter DA, Iron K, Austin PC, Naylor CD. Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada. JAMA 2004; 291(9):1100–1107.
   Google Scholar